CD33 and neoplasm: Incubation of primary AML samples with CD33- or CD123-redirected CAR T cells resulted in a significant upregulation of PD-L1 on AML blasts and the combination of CAR T cells with ICIs increased the anti-tumor effects of CAR T cells [95].